Supply Chain Constraints ‘Will Limit Vascepa Threat’
Dr Reddy’s And Hikma Have Path To Market
Supply is the million-dollar question for Vascepa ANDA sponsors, with Dr Reddy’s and Hikma receiving a further green light to introduce their generics into the US market.
